tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RCUS Stock Latest News

Gilead and Arcus Biosciences’ Promising Phase 3 Lung Cancer Study: Market Implications
Company AnnouncementsGilead and Arcus Biosciences’ Promising Phase 3 Lung Cancer Study: Market Implications
16d ago
GILD
RCUS
Gilead and Arcus Advance Promising Colorectal Cancer Study
PremiumCompany Announcements
Gilead and Arcus Advance Promising Colorectal Cancer Study
1M ago
GILD
RCUS
Gilead and Arcus Biosciences’ Promising Study on Advanced Gastrointestinal Cancers
PremiumCompany Announcements
Gilead and Arcus Biosciences’ Promising Study on Advanced Gastrointestinal Cancers
1M ago
GILD
RCUS
Positive Buy Rating for Arcus Biosciences Driven by Promising Trial Developments and Strategic Outlook
PremiumRatings
Positive Buy Rating for Arcus Biosciences Driven by Promising Trial Developments and Strategic Outlook
1M ago
RCUS
Arcus Biosciences Reports Strong Q2 2025 Results
PremiumCompany Announcements
Arcus Biosciences Reports Strong Q2 2025 Results
1M ago
RCUS
Arcus Biosciences reports Q2 EPS 0c, may not compare to consensus ($1.17)
PremiumThe FlyArcus Biosciences reports Q2 EPS 0c, may not compare to consensus ($1.17)
1M ago
RCUS
Arcus Biosciences Advances Phase 1 Study of AB521 in Cancer Treatment
Premium
Company Announcements
Arcus Biosciences Advances Phase 1 Study of AB521 in Cancer Treatment
1M ago
RCUS
Arcus Biosciences’ Promising Phase 3 Trial for Pancreatic Cancer
Premium
Company Announcements
Arcus Biosciences’ Promising Phase 3 Trial for Pancreatic Cancer
1M ago
RCUS
Gilead and Arcus Advance Immunotherapy Study in Lung Cancer
PremiumCompany Announcements
Gilead and Arcus Advance Immunotherapy Study in Lung Cancer
1M ago
GILD
RCUS
Arcus Biosciences Advances Cancer Treatment with AB801 Study
PremiumCompany Announcements
Arcus Biosciences Advances Cancer Treatment with AB801 Study
1M ago
RCUS
Arcus Biosciences Advances Cancer Treatment with AB598 Study
PremiumCompany Announcements
Arcus Biosciences Advances Cancer Treatment with AB598 Study
1M ago
RCUS
Gilead and Arcus Advance Promising Colorectal Cancer Study
PremiumCompany Announcements
Gilead and Arcus Advance Promising Colorectal Cancer Study
1M ago
GILD
RCUS
Arcus Biosciences’ Phase 3 Trial: A Potential Game-Changer in Pancreatic Cancer Treatment
PremiumCompany AnnouncementsArcus Biosciences’ Phase 3 Trial: A Potential Game-Changer in Pancreatic Cancer Treatment
1M ago
RCUS
Arcus Biosciences Advances Pancreatic Cancer Treatment with AB680 Study
Premium
Company Announcements
Arcus Biosciences Advances Pancreatic Cancer Treatment with AB680 Study
1M ago
RCUS
Gilead and Arcus Advance Cancer Treatment Study with AB308 and Zimberelimab
Premium
Company Announcements
Gilead and Arcus Advance Cancer Treatment Study with AB308 and Zimberelimab
1M ago
GILD
RCUS
Arcus Biosciences Advances Phase 1 Study for Cancer Treatment
PremiumCompany Announcements
Arcus Biosciences Advances Phase 1 Study for Cancer Treatment
1M ago
RCUS
Gilead and Arcus Biosciences’ Promising Lung Cancer Study: Market Implications
PremiumCompany Announcements
Gilead and Arcus Biosciences’ Promising Lung Cancer Study: Market Implications
2M ago
GILD
RCUS
AstraZeneca’s Promising Phase III Study on NSCLC Treatment: Key Insights for Investors
PremiumCompany Announcements
AstraZeneca’s Promising Phase III Study on NSCLC Treatment: Key Insights for Investors
2M ago
AZN
RCUS
Gilead and Arcus Biosciences’ Promising Phase 3 Lung Cancer Study Update
PremiumCompany Announcements
Gilead and Arcus Biosciences’ Promising Phase 3 Lung Cancer Study Update
2M ago
GILD
RCUS
Gilead Sciences and Arcus Biosciences: New Lung Cancer Treatment Combinations Under Evaluation
PremiumCompany AnnouncementsGilead Sciences and Arcus Biosciences: New Lung Cancer Treatment Combinations Under Evaluation
2M ago
GILD
RCUS
Arcus Biosciences quemliclustat granted orphan drug designation by FDA
Premium
The Fly
Arcus Biosciences quemliclustat granted orphan drug designation by FDA
2M ago
RCUS
Arcus Biosciences treatment of pancreatic cancer granted orphan designation
Premium
The Fly
Arcus Biosciences treatment of pancreatic cancer granted orphan designation
2M ago
RCUS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >